⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

U.S. farmer lawsuits over Syngenta GMO corn granted class status

Published 09/27/2016, 03:22 PM
© Reuters. Syngenta's logo is seen at Syngenta Biotech Center in Beijing
SYENF
-

(Reuters) - A U.S. district court judge in Kansas this week said lawsuits brought by U.S. farmers against seed company Syngenta AG (SIX:SYNN) over sales of biotech corn seeds not approved for import by China can proceed as a class action, according to a court filing.

Farmers from the largest U.S. corn-producing states sued the seed maker in 2014 after grain shipments containing traces of Syngenta's Agricure Viptera corn were rejected by China, which had not approved the variety for import before it was launched.

Farmers who did not plant Viptera corn claimed they suffered losses when the rejections that began in November 2013 disrupted trade and dragged down corn prices. Plaintiffs' attorneys estimate hundreds of thousands of corn growers lost $5 billion to $7 billion in current and future profits.

Judge John Lungstrum certified a nationwide class and statewide classes in Arkansas, Illinois, Iowa, Kansas, Missouri, Nebraska, Ohio and South Dakota.

"The Court's ruling will make it easier and less expensive for farmers to pursue their claims against Syngenta," said Scott Powell of Gray, Ritter & Graham, P.C., one of the attorneys appointed by the Court to represent the class.

Syngenta has said it is not responsible for the losses and that it launched Viptera corn in full compliance with all regulatory and legal requirements. The Swiss company is a major agricultural seed producer and the world's largest crop chemical maker.

The company said it may appeal the District Court's decision.

"Syngenta respectfully disagrees with this ruling, particularly given the widely varying ways in which farmers grow and sell corn in different markets across the U.S.," Syngenta spokesman Paul Minehart said.

© Reuters. Syngenta's logo is seen at Syngenta Biotech Center in Beijing

The multi-district litigation case is No. 14-md-2591-JWL.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.